Biontech Se ADR
(BNTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,563,350 | 12,623,620 | 14,618,810 | 2,002,633 | 1,382,422 |
| Marketable Securities | 7,598,182 | 5,287,360 | 199,552 | 451,471 | 156,762 |
| Receivables | 1,638,191 | 2,526,954 | 7,529,025 | 14,649,260 | 190,040 |
| Inventories | 306,559 | 387,139 | 463,163 | 594,508 | 73,244 |
| Other current assets | 240,988 | 309,327 | 286,471 | 134,168 | 101,626 |
| TOTAL | $20,347,270 | $21,134,400 | $23,097,020 | $17,832,040 | $1,904,095 |
| Non-Current Assets | |||||
| PPE Net | 1,012,088 | 819,518 | 641,853 | 381,550 | 259,266 |
| Investments And Advances | 1,356,953 | 1,272,893 | 84,499 | 25,200 | 0 |
| Intangibles | 1,267,139 | 1,262,611 | 231,476 | 239,459 | 186,755 |
| Other Non-Current Assets | 395,941 | 410,300 | 472,013 | 251,172 | 298,444 |
| TOTAL | $4,032,121 | $3,765,322 | $1,429,841 | $897,381 | $744,464 |
| Total Assets | $24,379,390 | $24,899,720 | $24,526,860 | $18,729,420 | $2,648,560 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 42,743 | 30,413 | 37,930 | 153,685 | 10,443 |
| Accounts payable and accrued liabilities | 461,732 | 383,134 | 215,040 | 189,296 | 116,844 |
| Other current liabilities | 2,221,010 | 1,258,607 | 2,227,943 | 1,919,934 | 564,963 |
| TOTAL | $2,730,355 | $2,240,902 | $3,108,752 | $4,119,081 | $692,250 |
| Non-Current Liabilities | |||||
| Long Term Debt | 232,327 | 206,719 | 185,644 | 203,020 | 263,925 |
| Other Non-Current Liabilities | 366,074 | 496,992 | 95,351 | 256,969 | 125,004 |
| TOTAL | $644,282 | $746,679 | $287,527 | $538,902 | $389,250 |
| Total Liabilities | $3,374,637 | $2,987,581 | $3,396,280 | $4,657,983 | $1,081,500 |
| Shareholders' Equity | |||||
| Common Shares | 269,010 | 269,060 | 261,925 | 291,398 | 281,360 |
| Retained earnings | 20,665,950 | 21,389,820 | 19,842,450 | 11,692,460 | N/A |
| Other shareholders' equity | -1,434,635 | -1,065,320 | -893,987 | 110,600 | 28,662 |
| TOTAL | $21,004,750 | $21,912,140 | $21,130,580 | $14,071,440 | $1,567,060 |
| Total Liabilities And Equity | $24,379,387 | $24,899,721 | $24,526,860 | $18,729,423 | $2,648,560 |